Almotriptan: meeting today's needs in acute migraine treatment.
about
The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study.A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraineAlmotriptan for the treatment of acute migraine: a review of early intervention trials.Triptan nonresponders: do they exist and who are they?Variability of the characteristics of a migraine attack within patients.
P2860
Almotriptan: meeting today's needs in acute migraine treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Almotriptan: meeting today's needs in acute migraine treatment.
@en
Almotriptan: meeting today's needs in acute migraine treatment.
@nl
type
label
Almotriptan: meeting today's needs in acute migraine treatment.
@en
Almotriptan: meeting today's needs in acute migraine treatment.
@nl
prefLabel
Almotriptan: meeting today's needs in acute migraine treatment.
@en
Almotriptan: meeting today's needs in acute migraine treatment.
@nl
P2860
P1476
Almotriptan: meeting today's needs in acute migraine treatment.
@en
P2093
Miguel J A Láinez
P2860
P304
P356
10.1586/14737175.7.12.1659
P577
2007-12-01T00:00:00Z